1. Home
  2. BBNX vs TRTX Comparison

BBNX vs TRTX Comparison

Compare BBNX & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • TRTX
  • Stock Information
  • Founded
  • BBNX 2015
  • TRTX 2014
  • Country
  • BBNX United States
  • TRTX United States
  • Employees
  • BBNX N/A
  • TRTX N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • TRTX Real Estate Investment Trusts
  • Sector
  • BBNX Health Care
  • TRTX Real Estate
  • Exchange
  • BBNX Nasdaq
  • TRTX Nasdaq
  • Market Cap
  • BBNX 649.9M
  • TRTX 632.5M
  • IPO Year
  • BBNX 2025
  • TRTX 2017
  • Fundamental
  • Price
  • BBNX $12.67
  • TRTX $8.19
  • Analyst Decision
  • BBNX Strong Buy
  • TRTX Strong Buy
  • Analyst Count
  • BBNX 10
  • TRTX 4
  • Target Price
  • BBNX $25.20
  • TRTX $9.50
  • AVG Volume (30 Days)
  • BBNX 467.2K
  • TRTX 743.5K
  • Earning Date
  • BBNX 07-29-2025
  • TRTX 07-29-2025
  • Dividend Yield
  • BBNX N/A
  • TRTX 11.78%
  • EPS Growth
  • BBNX N/A
  • TRTX N/A
  • EPS
  • BBNX N/A
  • TRTX 0.70
  • Revenue
  • BBNX $69,830,000.00
  • TRTX $148,005,000.00
  • Revenue This Year
  • BBNX $32.79
  • TRTX N/A
  • Revenue Next Year
  • BBNX $36.59
  • TRTX $9.19
  • P/E Ratio
  • BBNX N/A
  • TRTX $11.67
  • Revenue Growth
  • BBNX 38911.17
  • TRTX N/A
  • 52 Week Low
  • BBNX $8.89
  • TRTX $6.47
  • 52 Week High
  • BBNX $24.50
  • TRTX $9.66
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • TRTX 61.15
  • Support Level
  • BBNX N/A
  • TRTX $7.95
  • Resistance Level
  • BBNX N/A
  • TRTX $8.18
  • Average True Range (ATR)
  • BBNX 0.00
  • TRTX 0.15
  • MACD
  • BBNX 0.00
  • TRTX 0.02
  • Stochastic Oscillator
  • BBNX 0.00
  • TRTX 95.76

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: